bioRxivCancer BiologyPreprint
Functional Data Analysis of Spatial Clustering Identifies Prognostic T Cell Patterns in Ovarian Cancer
Chase J SakitisiD, Daisy LiaoiD, Brett M. ReidiD, Mary K. TownsendiD, Joellen M. SchildkrautiD, Andrew B. LawsoniD, Shelley S. TworogeriD, Kathryn L. TerryiD, Lauren Cole PeresiD, Julia WrobeliD, Alex C. SoupiriD, Brooke L. FridleyiD
Abstract
Spatial proteomic imaging technologies enable the simultaneous assessment of immune cell abundance and spatial organization within the tumor microenvironment. Spatial clustering is commonly summarized using measures such as Ripleys K or nearestOneighbor G-functions at a fixed radius. However, these approaches depend on scale selection and may obscure biologically relevant patterns occurring across spatial ranges. We propose a functional data analysis (FDA) framework to model spatial clustering trajectories derived across a continuum of radii. Functional principal component analysis (FPCA) was used to summarize dominant modes of spatial variation, and resulting scores were incorporated into Cox proportional hazards models as both main effects and interaction with immune cell abundance. The approach was applied to multiplex immunofluorescence data from five ovarian cancer studies, comprising 773 highOgrade ovarian serous tumors. Analyses focused on CD3+ and CD8+ T cell populations within the tumor compartment of the tissue, adjusting for age at diagnosis and cancer stage, with study-specific estimates combined using random-effects meta-analysis. Higher abundance of both T cells and CD8+ T cells was consistently associated with improved overall survival. Beyond abundance, spatial features captured by the leading functional principal component were independently associated with survival, particularly for CD8+ T cells. Interaction models further showed that the prognostic effect of immune infiltration depended on spatial clustering, with tumors characterized by high abundance and low spatial clustering exhibiting the most favorable outcomes. These findings indicate that spatial organization provides complementary prognostic information beyond abundance alone and suggests that more diffuse immune infiltration may reflect more effective anti-tumor activity in ovarian cancer. Overall, FDA offers a flexible and interpretable framework for modeling spatial clustering across scales and identifying prognostic spatial features not captured by fixed-radius or distance analyses.
- organism: human
- assay: imaging
- research focus: cell-cell communication
- research focus: protein structure prediction
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- FunSpace: A functional and spatial analytic approach to cell imaging data using entropy measures
Thao Vu, Souvik Seal, … Debashis Ghosh·PLoS Computational BiologyPeer-reviewed·Sep 27, 2023
- A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data
Sarah Samorodnitsky, Katie Marie Campbell, … Michael C. Wu·BioinformaticsPeer-reviewed·Jun 28, 2024
- The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma
L. B. Van Kleunen, M. Ahmadian, … A. Clauset·bioRxiv·Jan 26, 2024
- SPF: A Spatial and Functional Data Analytic Approach to cell Imaging data
Thao Vu, Julia Wrobel, … Debashis Ghosh·PLoS Computational BiologyPeer-reviewed·Jun 15, 2022
- Spatial profiling of ovarian clear cell carcinoma reveals immune-hot features
Y.-T. Tai, W.-C. Lin, … R. Y.-J. Huang·bioRxiv·Jul 27, 2023
- Spatial transcriptomics reveals tumour cell-intrinsic and microenvironmental features associated with survival in high-grade serous ovarian carcinoma
Md. Abdullah‐Al‐Kamran Khan, Weitao Lin, … Alistair R. R. Forrest·bioRxiv·Oct 5, 2026